Hemolytic Anemia Flashcards

1
Q

Excess hemolysis in spleen leads to

A

Excess hemolysis in spleen –> hypersplenism –> neutropenia and/or thrombocytopenia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q
A

as we have increased hemolysis we will have increase in bilirubin and iron.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q
A

unconjugated bilirubin is result of hemolysis.

converted to urobilirubin to be deficated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

classifications of hemolytic anemia

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

hemolytic anemis

clin man

A

Variable symptoms related to anemia
Dependent on abrupt or gradual onset
Fatigue
Dyspnea
Jaundice
Pallor
Splenomegaly
Discoloration of urine
Tea colored
Gallstones

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Hemolytic anemia

work up / Dx

A

Reticulocytes (% and absolute count) ↑
Bilirubin ↑ (Unconjugated/indirect)
AST ↑
LDH ↑ liverenzymes elevated
Haptoglobin ↓
or absent
Peripheral smear
Schistocytes (fragmented RBCs)
Macrocytes
UA
Hemoglobin
Hemosiderin
Coagulation Studies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Normocytic Intravascular Hemolysis

general

A
  • Direct trauma: bongo drummers, runners’ hemolysis
  • Shear stress: defective mechanical heart valves
  • Heat damage: thermal burns
  • Osmotic lysis following infusion of hypotonic solutions
  • Lysis from bacterial toxins (clostridial sepsis)
  • G6PD deficiency, TTP, DIC
  • Transfusion reaction
  • Immune mediated (antibodies)
    Nonimmune (transfusion of damaged RBCs)
  • RBCs phagocytized by macrophages in spleen and liver
  • Can occur with any condition that results in abnormal RBC morphology
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Extravascular Hemolytic anemia:

Intrinsic causes

A

Membrane defects
Glycolytic defects
Oxidation vulnerability
G6PD deficiency
Hemoglobinopathies
Sickle cell disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Extravascular Hemolytic anemias:

Extrinsic causes

A
  • Immune
    Autoimmune
    Drug toxicity
  • Microangiopathic
    Thrombotic Thrombocytopenic Purpura (TTP)
    Disseminated Intravascular Coagulation (DIC)
    Valve hemolysis
  • Infection
  • Hypersplenism
  • Burns
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Coombs test

Coombs positive

A

Autoimmune, Rh incompatibility (indirect Coombs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Coombs test

Coombs negative

A

Intrinsic red cell disease
Abnormal hemoglobin: sickle cell disease, thalassemia
Membrane defect: hereditary spherocytosis
Enzyme defect: G6PD deficiency
Extrinsic disease
Microangiopathic hemolytic anemia
TTP, DIC, prosthetic valve hemolysis
Splenic sequestration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Direct coombs test

A

take whole blood and remove plasma, then add reagent to the RBCs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Indirect Coombs test

A

remove RBCs and test the plasma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Immune Hemolytic Anemia

general

A

Acquired process
Distinct mechanisms:
True autoantibody directed against red cell antigen
molecule present on surface of red cells
Antibody directed against a certain molecule creates a reaction which secondarily damages or destroys RBCs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Immune hemolytic anemia

Cold vs Warm

A

Antibodies differ in optimum reactivity temps
“cold”
Complement mediated destruction at colder temperature (IgM)
Cold agglutinin disease
“warm”
RBC destruction at body temperature (IgG)
Autoimmune hemolytic anemia (AHIA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

AIHA

general and cause

A

Usually symptomatic
2’ to
Infection
EBV
CMV
HIV
Mycoplasma
Another disease
SLE
Other inflammatory disorders
Drugs
antibiotics most common culprits

17
Q

AIHA

clin man

A

Jaundice
Splenomegaly
Rapid progressing anemia
Peripheral smear: spherocytes
↑ reticulocytes
Indicates bone marrow response to anemia
+ Direct Coombs test
90% of patients

Indirect Coombs test +/-
LDH
Released from lysed RBCs
↓ or absent serum haptoglobin

18
Q

Haptoglobin and Hemoglobinuria

A
  • Hemolysis releases Hgb which is immediately bound by haptoglobin
  • Hgb-haptoglobin cleared from the plasma by liver
  • Hgb-haptoglobin binding overwhelms rate of haptoglobin synthesis, haptoglobin levels decrease
  • Excess hemoglobin filtered in the kidney and reabsorbed in proximal tubules.
  • Hemoglobinuria indicates severe intravascular hemolysis overwhelming absorptive capacity of renal tubular cells
19
Q

Hemolytic Anemia

Testing

A

Combination of ↑ LDH and ↓ haptoglobin is 90% specific for diagnosing hemolysis

Combination of normal LDH and serum haptoglobin >25 mg/dL is 92% sensitive for ruling out hemolysis

20
Q

AIHA

Tx

A

Hematology consultation- REFER

Acute
Steroids (acute)
Prednisone 1-2 mg/kg/day PO divided BID
May be difficult to crossmatch for blood transfusion due to antibodies
Therapeutic plasmapheresis
If severe anemia without available PRBC match
Rituximab IV weekly x 4 weeks
Refractory
IV Immunoglobulin (IVIG)
As adjunct to other treatments
Splenectomy

21
Q

Prednisone

MOA

A

Decreases inflammation by suppression of migration of polymorphonuclear leukocytes and reversal of increased capillary permeability
Suppresses the immune system by reducing activity and volume of the lymphatic system

Pregnancy: Crosses the placenta

22
Q

Prednisone

Adverse Rxn

A

Adverse Reactions (more common)
Facial erythema
Flushing/diaphoresis
Fluid retention
Headache
Impaired wound healing
Increased LFTs
Long term use causes adrenal suppression.

Any dosing > 1 week need to taper slowly! so that adrenal glands can wake back up

23
Q

Rituximab (Rituxan)

MOA and indications

A

MOA: Thought to eliminate B cells via apoptosis, antibody dependant cytotoxicity, and complement mediated cytotoxicity. Plasma cells responsible for long-term antibody production do not express CD20 and are not eliminated by rituximab
Dug Class: Monoclonal Antibody

Indications For AIHA

Initial therapy with glucocorticoids
Added to glucocorticoids if no improvement
Single agent initial therapy
Single agent for refractory disease

24
Q

Rituximab

Adverse effects

A

Adverse Effects
Infusion reaction (usually 1st reaction)
Long term immunosuppression
Reactivation of Hepatitis B
Pre-medications (30 minutes prior)
Acetaminophen
Antihistamine (Benadryl)
Methylprednisolone 100mg IV

25
Q

IV Immunoglobulin

MOAand adverse effect

A

MOA:
Interference with certain cell receptors of the reticuloendothelial system for autoimmune cytopenias and ITP
Provides passive immunity by increasing the antibody titer and antigen-antibody reaction potential
Dosing: Varies by diagnosis; SubQ/IV

Pregnancy: Crosses the placenta

Adverse reactions: Hypersensitivity reaction

26
Q

Cold agglutinin disease

general

A

Acquired hemolytic anemia due to IgM autoantibody (cold agglutinin)
Increased reactivity at low temperatures
Returns to warm central circulation and IgM antibody detaches leaving behind complement
Leads to sequestration in liver followed by destruction
Occurs in distal circulation (Fingers, nose, ears)
Usually idiopathic

27
Q

Cold Agglutinin Disease

may be seen with which diseases?

A

May be seen with:
Waldenstrom’s Macroglobulinemia
Lymphoma
Chronic Lymphocytic Leukemia (CLL)
Mycoplasma pneumonia
Viral infections such as
Mononucleosis
Measles
Mumps
CMV

28
Q

Cold aglutinin disease

S/Sx

A
  • Mottled or numb fingers or toes in cold
  • Acrocyanosis
  • Episodic low back pain
  • Episodic hemoglobinuria (after cold exposure)
29
Q

Cold Agglutinin Disease:

Labs

A
30
Q
A